Skip to main content
Premium Trial:

Request an Annual Quote

Novozymes Donates $500,000 to UC Davis Genome Center

NEW YORK, March 22 (GenomeWeb News) - Novozymes said on Friday that it has donated $500,000 to the UC Davis Foundation to support an endowed chair devoted to the director of the UC Davis Genome Center.

 

This gift, Novozymes said, has been matched by an equal contribution from the Universityof California.

 

According to the company, the center is in the process of recruiting 15 new faculty members in the areas of experimental genomics and bioinformatics. The center, Novozymes added, will be located in the new Genome and Biomedical Sciences facility, which is due to open this summer.

 

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.